Exane Derivatives’s Wintrust Financial WTFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,929
Closed -$1.2M 1022
2022
Q1
$1.2M Buy
+12,929
New +$1.26M 0.34% 69
2021
Q4
Sell
-19,607
Closed -$1.58M 1070
2021
Q3
$1.58M Buy
19,607
+609
+3% +$45K 0.38% 54
2021
Q2
$1.41M Sell
18,998
-272
-1% -$21.3K 0.32% 67
2021
Q1
$1.46M Buy
19,270
+1,792
+10% +$128K 0.42% 52
2020
Q4
$1.07M Buy
+17,478
New +$940K 0.31% 80
2019
Q2
Sell
-1,954
Closed -$132K 729
2019
Q1
$132K Sell
1,954
-418
-18% -$29.9K 0.03% 267
2018
Q4
$158K Hold
2,372
0.03% 272
2018
Q3
$202K Sell
2,372
-83
-3% -$7.39K 0.04% 242
2018
Q2
$218K Sell
2,455
-586
-19% -$53.8K 0.04% 254
2018
Q1
$253K Buy
3,041
+70
+2% +$6.03K 0.05% 226
2017
Q4
$245K Buy
2,971
+1,313
+79% +$106K 0.04% 223
2017
Q3
$130K Sell
1,658
-15
-0.9% -$1.11K 0.02% 229
2017
Q2
$128K Buy
+1,673
New +$120K 0.03% 248

Other funds holding WTFC

Exane Derivatives's WTFC Position: Q2 2022 in Review

Exane Derivatives sold out of Wintrust Financial (WTFC) in Q2 2022, closing a stake of 12,929 shares — an estimated $1.2M sold.

Exane Derivatives first reported a position in WTFC in Q2 2017 and held it in 13 quarters. The position peaked at $1.58M in Q3 2021. 349 funds tracked by Wall St. Rank hold WTFC as of Q2 2022.

  • Exane Derivatives reported no remaining Wintrust Financial position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 12,929 Wintrust Financial shares in Q2 2022, an estimated $1.2M.
  • Exane Derivatives first reported a position in Wintrust Financial in Q2 2017 and held it in 13 quarters.
  • Exane Derivatives's Wintrust Financial position peaked at $1.58M in Q3 2021.
  • 349 funds tracked by Wall St. Rank held Wintrust Financial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.